Top

Published in:

Open Access 01-11-2017 | ORIGINAL ARTICLE

Localization of parathyroid adenomas using ¹¹C-methionine pet after prior inconclusive imaging

Authors: Milou E Noltes, Annemieke M Coester, Anouk N A van der Horst-Schrivers, Bart Dorgelo, Liesbeth Jansen, Walter Noordzij, Clara Lemstra, Adrienne H Brouwers, Schelto Kruijff

Published in: Langenbeck's Archives of Surgery | Issue 7/2017

Abstract

Purpose

Minimally invasive parathyroidectomy (MIP) is the recommended treatment in primary hyperparathyroidism (pHPT) for which accurate preoperative localization is essential. The current imaging standard consists of cervical ultrasonography (cUS) and MIBI-SPECT/CT. ¹¹C-MET PET/CT has a higher resolution than MIBI-SPECT/CT. The aim of this study was to determine the diagnostic performance of ¹¹C-MET PET/CT after initial inconclusive or negative localization.

Methods

We performed a retrospective single center cohort study of patients with pHPT undergoing parathyroid surgery after prior negative imaging and later localization by means of ¹¹C-MET PET/CT between 2006 and 2014. Preoperative localization by ¹¹C-MET PET/CT was compared with later surgical localization, intraoperative quick PTH (IOPTH), duration of surgery, histopathology, and follow-up data. Also, differences in duration of surgery between the groups with and without correct preoperative localization were analyzed.

Results

In 18/28 included patients a positive ¹¹C-MET-PET/CT result corresponded to the surgical localized adenoma (64%). In 3/28 patients imaging was false positive and no adenoma was found. In 7/28 patients imaging was false negative at the side of the surgically identified adenoma. Sensitivity of ¹¹C-MET PET/CT was 72% (18/25). Duration of surgery of correctly localized patients was significantly shorter compared to falsely negative localized patients (p = 0.045).

Conclusion

In an intention to treat ¹¹C-MET-PET/CT correctly localized the parathyroid adenoma in 18/28 (64%) patients, after previous negative imaging. A preoperatively correct localized adenoma leads to a more focused surgical approach (MIP) potentially reducing duration of surgery and potentially healthcare costs.

Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, Haigh PI, Adams AL (2013) Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab 98:1122–1129. doi:10.1210/jc.2012-4022 CrossRefPubMedPubMedCentral

Clark OH, Duh Q, Kebebew E (2005) Textbook of endocrine surgery, 2nd edition ed. Elsevier Saunders, Philadelphia, pp 366–371

Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 94:335–339. doi:10.1210/jc.2008-1763 CrossRefPubMedPubMedCentral

Hindié E, Ugur O, Fuster D, O'Doherty M, Grassetto G, Ureña P, Kettle A, Gulec SA, Pons F, Rubello D, Parathyroid Task Group of the EANM (2009) 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging 36:1201–1216. doi:10.1007/s00259-009-1131-z CrossRefPubMed

Wei WJ, Shen CT, Song HJ, Qiu ZL, Luo QY (2015) Comparison of SPET/CT, SPET and planar imaging using 99mTc-MIBI as independent techniques to support minimally invasive parathyroidectomy in primary hyperparathyroidism: a meta-analysis. Hell J Nucl Med 18:127–135. doi:10.1967/s002449910207 PubMed

García-Talavera P, Díaz-Soto G, Montes AA, Villanueva JG, Cobo A, Gamazo C, Ruiz MÁ, González-Selma ML (2016) Contribution of early SPECT/CT to 99mTc-MIBI double phase scintigraphy in primary hyperparathyroidism: Diagnostic value and correlation between uptake and biological parameters. Rev Esp Med Nucl Imagen Mol S2253-654X:00043–00043. doi:10.1016/j.remn.2016.03.001

Lee GS, McKenzie TJ, Mullan BP, Farley DR, Thompson GB, Richards ML (2016) A multimodal imaging protocol,¹²³I/⁹⁹Tc-sestamibi, SPECT, and SPECT/CT, in primary hyperparathyroidism adds limited benefit for preoperative localization. World J Surg 40:589–594. doi:10.1007/s00268-015-3389-6 CrossRefPubMed

Joliat GR, Demartines N, Portmann L, Boubaker A, Matter M (2015) Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels. Langenbeck's Arch Surg 400:937–944. doi:10.1007/s00423-015-1358-z CrossRef

Michaud L, Balogova S, Burgess A, Ohnona J, Huchet V, Kerrou K, Lefèvre M, Tassart M, Montravers F, Périé S, Talbot JN (2015) A pilot comparison of 18F-fluorocholine PET/CT, ultrasonography and 123I/99mTc-sestaMIBI dual-phase dual-isotope scintigraphy in the preoperative localization of hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism: influence of thyroid anomalies. Medicine 94:e1701. doi:10.1097/MD.0000000000001701 CrossRefPubMedPubMedCentral

10.

Krakauer M, Wieslander B, Myschetzky PS, Lundstrøm A, Bacher T, Sørensen CH, Trolle W, Nygaard B, Bennedbæk FN (2016) A prospective comparative study of parathyroid dual-phase scintigraphy, dual-isotope subtraction scintigraphy, 4D-CT, and ultrasonography in primary hyperparathyroidism. Clin Nucl Med 41:93–100. doi:10.1097/RLU.0000000000000988 CrossRefPubMed

11.

Ozkaya M, Elboga U, Sahin E, Kalender E, Korkmaz H, Demir HD, Celen YZ, Erkılıç S, Gökalp A, Maralcan G (2015) Evaluation of conventional imaging techniques on preoperative localization in primary hyperparathyroidism. Bosn J Basic Med Sci 15(1):61–66. doi:10.17305/bjbms.2015.207 CrossRefPubMedPubMedCentral

12.

Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA (2012) A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol 19:577–583. doi:10.1245/s10434-011-1870-5 CrossRefPubMed

13.

Wong KK, Fig LM, Gross MD, Dwamena BA (2015) Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun 36:363–375. doi:10.1097/MNM.0000000000000262 CrossRefPubMed

14.

Sukan A, Reyhan M, Aydin M, Yapar AF, Sert Y, Canpolat T, Aktas A (2008) Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 22:123–131. doi:10.1007/s12149-007-0086-z CrossRefPubMed

15.

Steward DL, Danielson GP, Afman CE, Welga JA (2006) Parahyroid adenoma localization: surgeon performed ultrasound versus sestamibi. Laryngoscope 116:1380–1304. doi:10.1097/01.mlg.0000227957.06529.22 CrossRefPubMed

16.

Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF (2010) Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol 65:278–287. doi:10.1016/j.crad.2009.12.005 CrossRefPubMed

17.

Cetani F, Marcocci C (2013) The use of positron emission tomography with 11C-methionine in patients with primary hyperparathyroidism. Endocrine 43:251–252. doi:10.1007/s12020-013-9891-4 CrossRefPubMed

18.

Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH (2004) Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging 31:1405–1412. doi:10.1007/s00259-004-1610-1 CrossRefPubMed

19.

Habener JF, Maunus R, Dee PC, Potts JT Jr (1980) Early events in the cellular formation of proparathyroid hormone. J Cell Biol 85:292–298CrossRefPubMedPubMedCentral

20.

Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS (2013) Detection and characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between ¹¹C-methionine PET/CT and^99mTc-sestamibi scintigraphy. Nucl Med Mol Imaging 47:166–172. doi:10.1007/s13139-013-0212-x CrossRefPubMedPubMedCentral

21.

Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O'Doherty M, Palestro CJ, Scheve W, Stabin MG, Sylvestros D, Tulchinsky M (2012) SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol 40:111–118. doi:10.2967/jnmt.112.105122 CrossRefPubMed

22.

Phan HT, Jager PL, Plukker JT, Wolffenbuttel BH, Dierckx RA, Links TP (2008) Comparison of 11C-methionine PET and 18F fluorodeoxyglucose PET in differentiated thyroid cancer. Nucl Med Commun 29:711–716. doi:10.1097/MNM.0b013e328301835c CrossRefPubMed

23.

Beggs AD, Hain SF (2005) Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl Med Commun 26:133–136. doi:10.1097/00006231-200502000-00009 CrossRefPubMed

24.

Braeuning U, Pfannenberg C, Gallwitz B, Teichmann R, Mueller M, Dittmann H, Reimold M, Bares R (2015) 11C-methionine PET/CT after inconclusive 99mTc-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism. Nuklearmedizin 54:26–30. doi:10.3413/Nukmed-0686-14-07 CrossRefPubMed

25.

Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M (2014) 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery. J Clin Endocrinol Metab 99:4199–4205. doi:10.1210/jc.2014-1267 CrossRefPubMed

26.

Martinez-Rodriguez I, Martínez-Amador N, Arcocha-Torres M, Quirce R, Ortega-Nava F, Ibáñez-Bravo S, Lavado-Pérez C, Bravo-Ferrer Z, Carril JM (2014) Comparison of 99mTc-sestamibi and 11C-methionine PET/CT in the localization of parathyroid adenomas in primary hyperparathyroidism. Rev Esp Med Nucl Imagen Mol 33:93–98. doi:10.1016/j.remn.2013.08.002 PubMed

27.

Brown SJ, Lee JC, Christie J, Maher R, Sidhu SB, Sywak MS, Delbridge LW (2015) Four-dimensional computed tomography for parathyroid localization: a new imaging modality. ANZ J Surg 85:483–487CrossRefPubMed

28.

Hinson AM, Lee DR, Hobbs BA, Fitzgerald RT, Bodenner DL, Stack BC Jr (2015) Preoperative 4D CT localization of nonlocalizing parathyroid adenomas by ultrasound and SPECT-CT. Otolaryngol Head Neck Surg 153:775–778CrossRefPubMed

29.

Kluijfhout WP, Vriens MR, Borel Rinkes IH, Valk GD, de Klerk JM, de Keizer B (2015) 18F-fluorocholine PET-CT for localization of parathyroid adenomas. Ned Tijdschr Geneeskd 159:A8840PubMed

30.

Michaud L, Burgess A, Huchet V, Lefèvre M, Tassart M, Ohnona J, Kerrou K, Balogova S, Talbot JN, Périé S (2014) Is 18F-fluorocholine-poistron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 99:4531–4536CrossRefPubMed

Title: Localization of parathyroid adenomas using 11C-methionine pet after prior inconclusive imaging
Authors: Milou E Noltes
Annemieke M Coester
Anouk N A van der Horst-Schrivers
Bart Dorgelo
Liesbeth Jansen
Walter Noordzij
Clara Lemstra
Adrienne H Brouwers
Schelto Kruijff
Publication date: 01-11-2017
Publisher: Springer Berlin Heidelberg
Published in: Langenbeck's Archives of Surgery / Issue 7/2017
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI: https://doi.org/10.1007/s00423-017-1549-x

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Localization of parathyroid adenomas using ¹¹C-methionine pet after prior inconclusive imaging

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2017

Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies—new patients, old problem?

Underestimated risk of cancer in solitary thyroid nodules ≥3 cm reported as benign

Early prediction of hypocalcemia following thyroid surgery. A prospective randomized clinical trial

Results of surgical treatment for jejunal Crohn’s disease: choice between resection, strictureplasty, and combined treatment

Groin hernia diagnostics: dynamic inguinal ultrasound (DIUS)

Persistent perineal sinus after abdominoperineal resection